Cargando…
Expression of transforming growth factor β receptor II in mesenchymal stem cells from systemic sclerosis patients
OBJECTIVES: The present work aimed to evaluate the expression of transforming growth factor-β (TGF-β) receptors on bone marrow-derived multipotent mesenchymal stromal cells (MSCs) in patients with systemic sclerosis (SSc) and the consequences of TGF-β activation in these cells, since MSC have potent...
Autores principales: | Vanneaux, Valérie, Farge-Bancel, Dominique, Lecourt, Séverine, Baraut, Julie, Cras, Audrey, Jean-Louis, Francette, Brun, Cécilia, Verrecchia, Franck, Larghero, Jérôme, Michel, Laurence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549232/ https://www.ncbi.nlm.nih.gov/pubmed/23299111 http://dx.doi.org/10.1136/bmjopen-2012-001890 |
Ejemplares similares
-
Transforming growth factor-β increases interleukin-13 synthesis via GATA-3 transcription factor in T-lymphocytes from patients with systemic sclerosis
por: Baraut, Julie, et al.
Publicado: (2015) -
Human Muscle Progenitor Cells Displayed Immunosuppressive Effect through Galectin-1 and Semaphorin-3A
por: Lecourt, Séverine, et al.
Publicado: (2012) -
A Prospective Study of Bone Marrow Hematopoietic and Mesenchymal Stem Cells in Type 1 Gaucher Disease Patients
por: Lecourt, Séverine, et al.
Publicado: (2013) -
Circadian Clock Genes Modulate Human Bone Marrow Mesenchymal Stem Cell Differentiation, Migration and Cell Cycle
por: Boucher, Helene, et al.
Publicado: (2016) -
Human umbilical cord-derived mesenchymal stem/stromal cells: a promising candidate for the development of advanced therapy medicinal products
por: Mebarki, Miryam, et al.
Publicado: (2021)